Post Archive by Month

In recent years, international travel has rebounded at an extraordinary rate. According to the Department of Commerce, more than 15 million U.S. residents travel abroad monthly for business or vacation purposes.
Many of these international travelers are children, and just like adults, they have the option to enhance their immune systems by receiving travel vaccines.
When finalizing summer vaccination plans in 2025, disease prevention should be considered.

Encephalitis International has recently launched a global awareness campaign to emphasize the importance of vaccination against the growing threat of encephalitis, an inflammation of the brain's active tissues.
This initiative is essential since millions of international travelers visit encephalitis areas yearly.

With Chikungunya virus transmission occurring in approximately 100 countries in Africa, Asia, and the Americas and significant outbreaks reported in May 2025, researchers have identified an effective method to reduce this mosquito-transmitted disease's impact on local communities.
The findings from a new study suggest that the newly approved chikungunya vaccine represents an important new tool for controlling outbreaks.

The U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) today announced the development of the next-generation, universal vaccine platform, Generation Gold Standard.
This innovation uses a beta-propiolactone (BPL)-inactivated, whole-virus platform.